The implementation of cost containment measures, including the prescription drug provisions under the Inflation Reduction Act, as well as other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our product candidates if approved.
All entries for: Lineage Cell Therapeutics
April 29, 2025
Lineage Cell Therapeutics
Negative Outlook
Carlsbad, CA
51-200 employees
Disease Area: Multiple, Neurological Diseases, Oncology
Drug Type: Biologic